WEDNESDAY, March 14 (HealthDay News) -- The Israeli unsalable article maker Teva Pharmaceuticals has gained the pristine U.S. approval to market generic Lexapro (escitalopram) to discourse on depression and general anxiety disorder, the U.S. Food and put ~s into Administration said Wednesday.

Teva was granted 180-set time exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the supervision said in a news release.

Symptoms of major depression include depressed mood, loss of weal in once pleasurable activities, weight or zest change, sleep changes, feelings of offensiveness or worthlessness or thoughts of self-homicide.

Symptoms of general anxiety disorder hold exaggerated worry, always anticipating the overthrow, inability to relax and difficulty concentrating.

Escitalopram, to the degree that with similar antidepressants, has a boxed label portent about increased risk of suicidal thought, especially among children, teens and young adults. Other potential side effects include changes in sleep pattern, low sex drive, nausea and increased sweat, the FDA said.

Generic drugs possess the same high quality and brawniness as their brand-name predecessors, and sourness pass the same quality standards, the agency stressed. Brand-name Lexapro, produced ~ the agency of Forest Laboratories, was approved by the FDA in 2002.

More complaint

To learn more about this remedy, visit Medline Plus.

@yahoonews on Twitter, be suitable to a fan on Facebook